Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Terminated 2Completed 1

Sponsor Class

OTHER 36INDUSTRY 9NIH 4NETWORK 3OTHER_GOV 2

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 2Breast 1

Conditions

Squamous Intraepithelial Lesions 1Hot Flashes 1Endometrial Neoplasms 1Breast Neoplasms 1

Interventions

Radiotherapy 302Cisplatin 266Cyclophosphamide 230Doxorubicin 177Paclitaxel 171Vincristine 162Carboplatin 153Filgrastim 140Etoposide 139Gemcitabine 118Docetaxel 114Fluorouracil 113Methotrexate 106Dexamethasone 106Cytarabine 106Prednisone 92Leucovorin 90Gene Expression Profiling 82Granulocyte Colony-Stimulating Factor 75Specimen Handling 71Magnetic Resonance Spectroscopy 64Irinotecan 59Capecitabine 59Radiation 54Polymerase Chain Reaction 51Ifosfamide 51Rituximab 49Immunohistochemistry 49Daunorubicin 49Oxaliplatin 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Megestrol Acetate × Clear all
NCT00503581 2020-11-03

Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia

GOG Foundation

Phase 2 Terminated
9 enrolled 5 charts
Gynecologic

Squamous Intraepithelial Lesions

NCT00005975 2015-11-18

S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast Cancer

SWOG Cancer Research Network

Phase 3 Completed
288 enrolled
Breast

Breast Neoplasms, Hot Flashes

NCT00016341 2013-04-11

Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer

GOG Foundation

Phase 3 Terminated
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡